KIOS-FM

Johnson & Johnson

PBS

Nebraska plans to immediately resume using Johnson & Johnson’s coronavirus vaccine after federal health officials decided the shot’s benefits outweigh a rare risk of developing blood clots. The Nebraska Department of Health and Human Services announced the decision on Monday. Federal health officials gave the OK to resume using the shots Friday.